Response to "stereotactic Ablative Radiotherapy in the Framework of Classical Radiobiology: Response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "influence of Tumor Hypoxia on Stereotactic Ablative Radiotherapy (SABR): Response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600)

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages 1193-

  Song, Chang W ^a   Levitt, Seymour H ^a   Park, Heonjoo ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOSENSITIZING AGENT;

CANCER RADIOTHERAPY; CANCER SURVIVAL; HYPOXEMIA; LETTER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; STEREOCTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC TREATMENT; TUMOR CELL; TUMOR HYPOXIA; TUMOR MODEL;

CELL HYPOXIA; CELL SURVIVAL; HUMANS; OXYGEN CONSUMPTION; RADIATION TOLERANCE; RADIOSURGERY;

EID: 80155123440     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.021     Document Type: Letter

References (3)

1. J. Meyer, and R. Timmerman Stereotactic ablative radiotherapy in the framework of classical radiobiology: Response to Drs. Brown, Diehn, and Loo Int J Radiation Oncol Bio Phys 79 2011 1599 1600
2. M. Brown, B. Loo, and M. Diehn Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): Response to Drs. Mayer and Timmerman Int J Radiation Oncol Biol Phys 79 2011 1600
3. J.M. Brown, M. Diehn, and B.W. Loo Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer Int J Radiat Oncol Biol Phys 78 2010 323 327